SARCOPENIA E MALNUTRIZIONE: ASPETTI LEGATI ALLA PROGNOSI - Dott.ssa Elisa D'Angelo UO Radioterapia Oncologica Azienda Ospedaliero Universitaria ...

Page created by Vernon Cruz
 
CONTINUE READING
SARCOPENIA E
                                                          MALNUTRIZIONE: ASPETTI
                                                           LEGATI ALLA PROGNOSI

Dott.ssa Elisa D’Angelo
UO Radioterapia Oncologica
Azienda Ospedaliero Universitaria Policlinico di Modena
MALNUTRIZIONE E SARCOPENIA: PROGNOSI IN HNSCC

    • LA PRESENZA DI SARCOPENIA E MALNUTRIZIONE, POSSONO AIUTARCI A
      PREVEDERE LA PROGNOSI DI UN PAZIENTE AFFETTO DA NEOPLASIA DEL
      DISTRETTO TESTA E COLLO?
    • POSSONO SARCOPENIA E MALNUTRIZIONE ESSERE CONSIDERATI COME
      FATTORI PROGNOSTICI?

                                                                      2
PROGNOSI DEL HNSCC

                     AIRTUM, registro 2020; SEER database 2017   3
MALNUTRIZIONE E SARCOPENIA

 • MALNUTRITION: «a state resulting from lack of intake or uptake of nutrition that
   leads to altered body composition(decreased fat free mass) and body cell mass
   leading to diminished physical and mental function and impaired clinical outcome
   from disease»
 • SARCOPENIA: «syndrome of its own characterized by the progressive and
   generalised loss of skeletal muscle mass, strength and function (performance) with a
   consequent risk of adverse outcomes»

                                                                    T. Cederholm , 2017   4
MALNUTRIZIONE

DRM is a specific type of malnutrition caused by a concomitant disease. DRM is triggered mainly by a
disease-specific inflammatory response.

DRM with inflammation is a catabolic condition characterized by an inflammatory response, including
anorexia and tissue breakdown, elicited by an underlying disease.
                                                                              T. Cederholm , 2017      5
PREVALENZA IN HNSCC

                      1952 pazienti

                                      6
Malnutrizione legata al cancro

                                                                     7
                                 Arends, 2017; T. Cederholm , 2017
SARCOPENIA: MECCANISMO

                                               8
                         Ongaro et al., 2017
• SARCOPENIA
  E CACHESSIA

                                9
                Argiles, 2014
MALNUTRIZIONE: COME VALUTARLA?

                                  10
Cederholm , 2019
MALNUTRIZIONE: COME VALUTARLA?

                                  11
Cederholm, 2019
Sarcopenia: come valutarla?

                              Conclusions: Despite the different
                              existing body composition
                              assessment tools, it seems that
                              skeletal muscle mass (SMM)
                              measurement at the level of
                              cervical spine C3 vertebra may be
                              a reliable method for SMM
                              assessment as it strongly
                              correlates with cross-sectional
                              area measures at the level of L3
                              and it allows a cost-effective body
                              composition assessment without
                              the need for additional radiation
                              exposure.
                                                        12
Sarcopenia ed impatto prognostico

• To determine whether radiologically
  defined sarcopenia at the C3 or L3 level
  as measured by computed tomography
  or magnetic resonance imaging is
  prognostic of overall survival (OS) in
  head and neck cancers (HNCs).

• Ruolo della sarcopenia radiologica ed
  impatto sulla OS nel paziente
• Dei dieci studi selezionati nella
  metanalisi, 8 dimostrano un impatto
  della sarcopenia radiologicamente
  misurata sulla OS nei pazienti hnscc

                                                          13
                                             Wong, 2020
Sarcopenia e impatto prognostico: metanalisi studi in pazienti in cura per HNSCC

  A total of 6211 studies with 1059 pooled
  patients.
  Sarcopenia prevalence ranged from 6.6 to
  64.6% pre-treatment and 12.4 to 65.8%
  post-treatment. Pre-treatment sarcopenia
  was associated with reduced overall survival
  (HR 2.07; 95%CI, 1.47e2.92, p < 0.0001, I2 ¼
  49%) with similar findings for post-
  treatment sarcopenia (HR 2.93; 95%CI,
  2.00e4.29, p < 0.00001, I2 ¼ 0%) with
  moderate to low heterogeneity exhibited
  amongst studies respectively. The certainty
  of evidence for overall survival according to
  GRADE was low for pre-treatment
  sarcopenia and moderate for post-treatment
  sarcopenia
     CT-defined sarcopenia is independently associated with reduced overall survival in patients
     with HNC and holds a clinically meaningful prognostic value. Consensus regarding sarcopenia
     assessment and definitions is warranted                                                                       14
                                                                                                   Findlay, 2020
Sarcopenia ed impatto prognostico:

PROSPECTIVE
                                                                                    Stratificati per PS
Sarcopenia (CT to C3)
                                                                                    WHO
750 pts HNSCC

                                                                                     Stratificati per stadio
                                                                                     di malattia

   Sarcopenic patients had significantly poorer survival rates, especially those with lower
         performance status and locally advanced disease. STRONG ASSOCIATION                  Van Rijn Dekker, 2020   15
           Skeletal muscle depletion is a marker of more advanced disease…???
MALNUTRIZIONE E SARCOPENIA: PROGNOSI IN HNSCC

    • LA PRESENZA DI SARCOPENIA E MALNUTRIZIONE, POSSONO AIUTARCI A
      PREVEDERE LA PROGNOSI DI UN PAZIENTE AFFETTO DA NEOPLASIA DEL
      DISTRETTO TESTA E COLLO?
    • POSSONO SARCOPENIA E MALNUTRIZIONE ESSERE CONSIDERATI COME
      FATTORI PROGNOSTICI?
    • PERCHÉ LA SARCOPENIA IMPATTA SULLA OS?

                                                                      16
Sarcopenia ed impatto prognostico: compliance ai trattamenti

                                                          sarcopenia is
                                                          significantly
                                                          associated with
                                                          grade physician-
                                                          rated xerostomia
                                                          and dysphagia

                                                         Van Rijn Dekker, 2020   17
Sarcopenia ed impatto prognostico: compliance ai trattamenti

                                          PROSPECTIVE: ….Optimal nutritional support follow-up,
                                          including weekly consultation with a dietician and an
                                          oncologist and daily weight monitoring, was performed.
                                          Sarcopenia was determined by measuring the skeletal
                                          muscles at the L3 vertebra on the planning CT scan for
                                          radiotherapy. For each treatment group (RT or RTCT), we
                                          assessed the prognostic value of sarcopenia for disease-free
                                          survival (DFS) and overall survival (OS) and its impact on
                                          treatment-related toxicity.

                                          RESULTS:
                                          Overall, sarcopenia was associated with OS and DFS in a
                                          multivariate analysis (HR 1.9 [1.1–3.25] and 1.7 [1.06–2.71],
                                          respectively).
                                          Sarcopenia was not related to higher treatment-related
                                          toxicity

                                                                                                          18
                                                                          Thureau, 2021
Impatto prognostico della sarcopenia in HNSCC
     sottoposti a CRT definitiva

221 patients with head and neck cancer:
definitive CCRT
Sarcopenia was defined as an L3 muscle
index of
Impatto della sarcopenia in HNSCC sottoposti a
                 CRT definitiva

         Sarcopenia alone did not decrease survival among our patients

                                                                            20
                                                                Cho, 2018
Sarcopenia ed infiammazione impatto sulla prognosi in HNSCC

                                                 sarcopenia may reflect the increased metabolic activity of
                                                 more aggressive tumors, leading to systemic inflammation
                                                 and muscle wasting

     Sarcopenia was closely associated with PFS and OS when
     accompanied by systemic inflammation (WBC, ANC, and NLR).
                                                                                                               21
                                                                                Cho, 2018; Muscaritoli, 2017
Sarcopenia ed interruzione RT in HNSCC

                                         22
MALNUTRIZIONE CANCRO-ASSOCIATA

                                 23
MALNUTRIZIONE CANCRO-ASSOCIATA

     Both % of weight loss and BMI independently predict survival (P < 0.01)

                                                                               24
MALNUTRIZIONE CANCRO-ASSOCIATA

                                                                  Risk of reduced survival is a
                                                               function of BMI and % weight loss.

BMI-adjusted WL grading system is a useful tool in efforts to predict survival because it is independent
of cancer site, stage, and PS and strongly discriminates survival differences.

                                                                                               25
CONCLUSIONI

              26
CONCLUSIONI

              Welch ML, Jaffray DA. 2017
You can also read